mRNA-based SARS-CoV-2 vaccination is associated with reduced ICU admission rate and disease severity in critically ill COVID-19 patients treated in Switzerland

mRNA-based SARS-CoV-2 vaccination is associated with reduced ICU admission rate and disease severity in critically ill COVID-19 patients treated in Switzerland

Saved in:
Bibliographic Details
Published in:Intensive care medicine Vol. 48; no. 3; pp. 362 - 365
Main Authors: Hilty, Matthias Peter, Keiser, Stefanie, Wendel Garcia, Pedro D., Moser, André, Schuepbach, Reto A.
Format: Journal Article
Language:English
Published: Berlin/Heidelberg Springer Berlin Heidelberg 01-03-2022
Springer
Springer Nature B.V
Subjects:
Anesthesiology
COVID-19
COVID-19 Vaccines
Critical Care Medicine
Critical Illness
Emergency Medicine
Humans
Intensive
Intensive Care Units
Letter
Medicine
Medicine & Public Health
Messenger RNA
mRNA
Pain Medicine
Pediatrics
Pneumology/Respiratory System
RNA, Messenger
SARS-CoV-2
Severe acute respiratory syndrome coronavirus 2
Severity of Illness Index
Switzerland
Vaccination
Switzerland
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Bibliography:SourceType-Other Sources-1
ObjectType-Article-2
content type line 63
ObjectType-Correspondence-1
ISSN:0342-4642
1432-1238
DOI:10.1007/s00134-021-06610-z